On Sunday at the Endocrine Society's Annual Meeting in Chicago, Danish biopharmaceutical company H. Lundbeck presented a result that endocrinologists tracking Cushing's disease drug development have ...
A once-daily pill that blocks a key adrenal receptor slashed androgen levels by 67% while allowing most patients to reduce their steroid doses to normal physiologic levels, Crinetics Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results